Abstract P6-04-27: EBAG9 immunoreactivity is a potential prognostic factor for poor outcome of breast cancer patients with adjuvant tamoxifen therapy
2010 ◽
2008 ◽
Vol 99
(8)
◽
pp. 1706-1707
◽
2008 ◽
Vol 99
(5)
◽
pp. 995-999
◽
2003 ◽
Vol 79
(1)
◽
pp. 11-16
◽
2009 ◽
Vol 119
(1)
◽
pp. 53-61
◽
1991 ◽
Vol 83
(18)
◽
pp. 1299-1306
◽
2000 ◽
Vol 33
(6)
◽
pp. 513-516
◽